3D human models of disease at scale
SCREENING
TECHNOLOGIES
ABOUT OUR
BETTER DATA
OUR
Cell and Gene therapies
TESTING MULTIPLE
MODALITIES
SCREENING
TECHNOLOGIES
3D human models of disease at scale
ABOUT OUR
OUR
BETTER DATA
Cell and Gene therapies
TESTING MULTIPLE
MODALITIES
OUR VISION
To revolutionize drug discovery and clinical trials with our disruptive screening technologies.
Empower drug developers to produce better drugs, faster and with less costs, for the benefit of patients and society.
WHAT THEY SAY
“This is a fantastic technology which has direct application in target discovery, combination screening in discovery and determining treatment regimes in the clinic.”
Steve Rees, Vice President Discovery Biology at AstraZeneca
TECHNOLOGY
enabling versatile 3D ex vivo assays for precision drug screening
Large Throughput
Generate large data sets with rare or small samples
Relevant Models
Mimic human disease environments at scale
Customer-defined Assays
Tailor cell types, assay duration and endpoints for your needs
Open platform
